Impaired Th1 cytokine production in spondyloarthropathy is restored by anti-TNFalpha - Wikidata - wikimedia - TriplyDB

Impaired Th1 cytokine production in spondyloarthropathy is restored by anti-TNFalpha

Impaired Th1 cytokine production in spondyloarthropathy is restored by anti-TNFalpha

http://www.wikidata.org/entity/Q35550729

about

Infiltration of the synovial membrane with macrophage subsets and polymorphonuclear cells reflects global disease activity in spondyloarthropathy Therapy of ankylosing spondylitis and other spondyloarthritides: established medical treatment, anti-TNF-alpha therapy and other novel approaches Paradoxical reactions under TNF-α blocking agents and other biological agents given for chronic immune-mediated diseases: an analytical and comprehensive overview Anti-TNF-alpha therapy in ankylosing spondylitis.Treatment of active spondyloarthropathy with infliximab, the chimeric monoclonal antibody to tumour necrosis factor alpha.How tumour necrosis factor blockers interfere with tuberculosis immunity.Th2 mediated regulation in RA and the spondyloarthropathies.Ankylosing spondylitis: introductory comments on its diagnosis and treatment.Anti-tumour necrosis factor alpha therapy for ankylosing spondylitis: international experience Cytokines in the seronegative spondyloarthropathies and their modification by TNF blockade: a brief report and literature review.Cytokine and chemokine receptor profile of peripheral blood mononuclear cells during treatment with infliximab in patients with active rheumatoid arthritis.Preferential type 1 chemokine receptors and cytokine production of CD28- T cells in ankylosing spondylitis.Immunohistological examination of open sacroiliac biopsies of patients with ankylosing spondylitis: detection of tumour necrosis factor alpha in two patients with early disease and transforming growth factor beta in three more advanced cases.Cellular and humoral mechanisms involved in the control of tuberculosis Association of cytokine and matrix metalloproteinase profiles with disease activity and function in ankylosing spondylitis.Activation-Induced Killer Cell Immunoglobulin-like Receptor 3DL2 Binding to HLA-B27 Licenses Pathogenic T Cell Differentiation in Spondyloarthritis.Anti-TNF immunotherapy reduces CD8+ T cell-mediated antimicrobial activity against Mycobacterium tuberculosis in humans Infliximab in the treatment of ankylosing spondylitis.Management of ankylosing spondylitis with infliximab.New-onset vitiligo and progression of pre-existing vitiligo during treatment with biological agents in chronic inflammatory diseases.Building consensus on nomenclature and disease classification for ankylosing spondylitis: results and discussion of a questionnaire prepared for the International Workshop on New Treatment Strategies in Ankylosing Spondylitis, Berlin, Germany, 18-19 Association of CD163+ macrophages and local production of soluble CD163 with decreased lymphocyte activation in spondylarthropathy synovitis.Decreased Th17 and Th1 cells in the peripheral blood of patients with early non-radiographic axial spondyloarthritis: a marker of disease activity in HLA-B27⁺ patients.Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondylarthropathy.Changes in T cell effector functions over an 8-year period with TNF antagonists in patients with chronic inflammatory rheumatic diseases.Aberrant regulation of interleukin-12 receptor beta2 chain on type 1 cytokine-stimulated T lymphocytes in type 1 diabetes Interleukin 10 polymorphisms in ankylosing spondylitis

P2860

Q24804272-A9A7E603-4538-4EBB-9430-AB92CC0B42F2 Q24806367-398BD7B5-806D-40B4-9224-CFA97D680EE3 Q26738918-4174BC12-0258-4B48-A9A7-60044E1E8E66 Q33204138-643F9B7C-A1F0-47A8-BD29-6AD30B60FB18 Q34560557-83271AF7-7FF5-4548-BC06-92C6E9B313FB Q34660051-84E34839-9F53-4ECF-B482-486B5E5EA79F Q34962858-872A0863-D9C1-409E-810F-119583F05DE2 Q34967487-47B2A72F-FEB8-4C99-9957-7F0DDCB34C45 Q34967541-2D9B0765-124E-4223-9369-D8ABD9347954 Q35552298-DEA4BE38-D188-4903-91C3-693DA9AFA8C8 Q35554196-D4340052-D698-4E59-940D-C9329EB6F432 Q35637105-C4C56049-93DA-4AAC-A6D6-BE211C1EC9ED Q35637293-4D28077B-0C98-46DC-9604-3C5FD0BC0222 Q35996521-4758FEE8-2490-4CF9-B12F-8EF69073CF03 Q36246052-1B86E57A-0438-4F53-BCA0-5E5CAFB2E599 Q36866358-DFCC5075-E31D-4769-8BB9-A61070FE3E03 Q37170834-F9014787-1B8C-4D7E-BA7C-6F47B8C17E2C Q37290474-B601FF10-A9EC-4F91-8C2E-83B9B2D610DC Q38993236-291BCA0F-E022-4E03-AC18-CABA79D87F9A Q39690095-62B5E8B4-EBB2-46D4-880F-71A4C01CC049 Q40627164-96983CAD-CB61-4653-A0E8-9820FEA3D89C Q47596781-5690477E-F154-4F59-86C2-52B1C8F0195F Q48372764-E6A23636-119F-45C7-9150-58BF8B2D5A82 Q49049736-9330CB73-E808-4B70-A2E1-54B22449B80F Q55305483-02DAFD36-783B-4695-B6EA-60FA56CCCCCB Q57449365-0208C985-1E3D-4C73-8118-794986007AF3 Q57667832-1A2A0BA7-1036-452C-94D8-62560EAFB052

P2860

Impaired Th1 cytokine production in spondyloarthropathy is restored by anti-TNFalpha

http://www.wikidata.org/entity/Q35550729

description

2001 nî lūn-bûn

@nan

2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Impaired Th1 cytokine production in spondyloarthropathy is restored by anti-TNFalpha

@ast

Impaired Th1 cytokine production in spondyloarthropathy is restored by anti-TNFalpha

@en

type

label

Impaired Th1 cytokine production in spondyloarthropathy is restored by anti-TNFalpha

@ast

Impaired Th1 cytokine production in spondyloarthropathy is restored by anti-TNFalpha

@en

prefLabel

Impaired Th1 cytokine production in spondyloarthropathy is restored by anti-TNFalpha

@ast

Impaired Th1 cytokine production in spondyloarthropathy is restored by anti-TNFalpha

@en

P1433

Q35550729-F7132DC2-9A29-458B-916F-3452147E6129

P1476

Q35550729-E4224C6F-972E-447E-9AAC-0913F694C6D3

P2093

Q35550729-0B53E734-43A3-479A-AAC9-05FFF8171BAF

Q35550729-13B3B131-3D65-4D65-AB67-43B1DC40368D

Q35550729-23EF2B6D-F936-42EE-A55F-9F24E2882611

Q35550729-6F353D2A-A32A-4F91-AFB3-3CB3D1D76781

Q35550729-7B2D462F-332D-40DD-913B-AA5E8E5723A7

Q35550729-93005CD8-DF80-4D53-969A-91D1B3B02BD4

Q35550729-96C6FCF9-EC81-4D4F-9719-8D5DB2AC1614

Q35550729-F6A8E47D-3A05-4CB7-86D8-340E182267A3

P2860

Q35550729-1052837E-0C31-4105-A1AB-30224B536AE2

Q35550729-1D97B6DB-5791-41A4-910C-384BD5D49522

Q35550729-205F1223-B240-4EE5-8592-43B337062AA1

Q35550729-3DB34D13-FCA0-4D90-BE28-41C9DA39039B

Q35550729-3FA7BBD0-99F4-4A0F-BC29-D2939DB9D96E

Q35550729-4A18B89F-1AAD-4E2D-B3E0-34F831925C18

Q35550729-5F56D1B7-D97B-45BB-B45B-54A37335BDEA

Q35550729-675288BD-6762-4657-B958-F2FABA760B5A

Q35550729-811F0531-EF61-4F93-8D69-87EDC70CE1C5

Q35550729-86D9D9F3-599F-4F8E-AE76-E353D9C9A2B6

P304

Q35550729-2DD0AE82-2777-4299-929A-0FB478396BC0

P31

Q35550729-27A6A6D7-99BA-41C8-9F3A-2B2682ACA693

P356

Q35550729-0469DCFB-F056-45B6-AD79-0E1B21A18774

P407

Q35550729-D078BC59-3B09-4469-AE01-875C297B8C97

P433

Q35550729-703FFDD4-E26B-4009-97F2-182478343BA3

P478

Q35550729-3D933361-7186-4F7C-9C29-F63B78557425

P577

Q35550729-EEAE9C17-F093-49DC-80F0-627BEE359192

P5875

Q35550729-EFCCA362-ADEC-4572-9E95-B109BC5303E0

P698

Q35550729-7766AFFD-3CC5-457D-85B9-D952C3CBBECB

P932

Q35550729-141B7F04-1318-4EFB-90ED-F9310E23A8F8

P356

P1433

Annals of the Rheumatic Diseases

P1476

Impaired Th1 cytokine production in spondyloarthropathy is restored by anti-TNFalpha

@en

P2093

Baeten D

http://www.w3.org/2001/XMLSchema#string

De Keyser F

http://www.w3.org/2001/XMLSchema#string

De Vos M

http://www.w3.org/2001/XMLSchema#string

Kruithof E

http://www.w3.org/2001/XMLSchema#string

Mielants H

http://www.w3.org/2001/XMLSchema#string

Van Damme N

http://www.w3.org/2001/XMLSchema#string

Van den Bosch F

http://www.w3.org/2001/XMLSchema#string

Veys EM

http://www.w3.org/2001/XMLSchema#string

P2860

The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis

TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties

Functional diversity of helper T lymphocytes

Cytokine patterns in the pathogenesis of human leishmaniasis.

The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy.

Anti-tumor necrosis factor modulates anti-CD3-triggered T cell cytokine gene expression in vivo.

Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor/CD3 complex; reversal in vivo by anti-TNF antibodies in patients with rheumatoid arthritis.

Differential Th1/Th2 cytokine patterns in chronic arthritis: interferon gamma is highly expressed in synovium of rheumatoid arthritis compared with seronegative spondyloarthropathies

Effects of a loading dose regimen of three infusions of chimeric monoclonal antibody to tumour necrosis factor alpha (infliximab) in spondyloarthropathy: an open pilot study.

Crucial role of interleukin-10/interleukin-12 balance in the regulation of the type 2 T helper cytokine response in reactive arthritis.

P304

750-755

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/ARD.60.8.750

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

60

http://www.w3.org/2001/XMLSchema#string

P577

2001-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

245922002

http://www.w3.org/2001/XMLSchema#string

P698

11454638

http://www.w3.org/2001/XMLSchema#string

P932

1753790

http://www.w3.org/2001/XMLSchema#string